cardiology careers collections past issues search home
     

J Am Coll Cardiol, 1999; 33:1974-1980
© 1999 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tse, H.-F.
Right arrow Articles by Ayers, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tse, H.-F.
Right arrow Articles by Ayers, G. M.

CLINICAL STUDIES

Implantable atrial defibrillator with a single-pass dual-electrode lead

Hung-Fat Tse, MBBS*, Chu-Pak Lau, MD*, Barry M. Yomtov, MSEBE{dagger} and Gregory M. Ayers, MD, PhD{dagger}

* Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
{dagger} InControl Inc., Redmond, Washington, USA

Manuscript received August 13, 1998; revised manuscript received January 29, 1999, accepted March 1, 1999.

Reprint requests and correspondence: Prof. Chu-Pak Lau, Chief, Division of Cardiology, Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong, China
cplau{at}hkucc.hku.hk

OBJECTIVES

We examined the feasibility and efficacy of using a single-pass, dual-electrode (Solo) lead for atrial fibrillation (AF) detection and defibrillation.

BACKGROUND

The efficacy and safety of an implantable atrial defibrillator (IAD) has been extensively studied; however, separate right atrial (RA) and coronary sinus (CS) defibrillation leads are used for the present system.

METHODS

We studied the use of the Solo lead for AF detection and defibrillation in 17 patients who underwent cardioversion of chronic AF. The Solo lead with a proximal 6-cm RA electrode and a distal 6-cm spiral-shaped CS electrode were positioned into the CS with the RA electrode against the anterolateral RA wall. The RA-CS electrogram signal amplitudes were measured and the efficacy of the Solo lead for AF detection and defibrillation was assessed by using an external version of the IAD.

RESULTS

The leads were inserted in all patients without complication (mean fluoroscopy time: 13.3 ± 6.8 min). The mean RA-CS signal amplitude was 484 ± 229 µV during sinus rhythm and 274 ± 88 µV during AF (p < 0.05). All patients had satisfactory atrial signal amplitude to allow accurate detection of sinus rhythm. Successful cardioversion was achieved in 16/17 (94%) patients with an atrial defibrillation threshold of 320 ± 70 V (5.5 ± 2.7 J). Insufficient interelectrode spacing resulted in suboptimal electrode locations, associated with a lower atrial signal amplitude, a higher atrial defibrillation threshold and diaphragmatic stimulation.

CONCLUSIONS

These results suggest a simplified lead configuration with optimal interelectrode spacing can be used with an IAD for AF detection and defibrillation.

Abbreviations and Acronyms
  AF = atrial fibrillation
  CS = coronary sinus
  IAD = implantable atrial defibrillator
  RA = right atrium




This article has been cited by other articles:


Home page
ChestHome page
P. McKeown and A. E. Epstein
Future Directions: American College of Chest Physicians Guidelines for the Prevention and Management of Postoperative Atrial Fibrillation After Cardiac Surgery
Chest, August 1, 2005; 128(2_suppl): 61S - 64S.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078.
[Full Text] [PDF]



 
  cardiology careers collections past issues search home